In a similar study where a microfluidic chip was used for immunocapture and quantification of circulating EVs from patients with BC, a significant increase in the EpCAM-positive EV expression level was detected compared to healthy controls, whereas EV HER2 expression levels were almost consistent with that in tumour tissues assessed by immunohistochemical staining [168]. This evidence concerns the gene EPCAM and breast cancer.